KR850001339B1 - 페니실란산 1,1-디옥사이드 및 그의 에스테르의 제조방법 - Google Patents

페니실란산 1,1-디옥사이드 및 그의 에스테르의 제조방법 Download PDF

Info

Publication number
KR850001339B1
KR850001339B1 KR1019800000885A KR800000885A KR850001339B1 KR 850001339 B1 KR850001339 B1 KR 850001339B1 KR 1019800000885 A KR1019800000885 A KR 1019800000885A KR 800000885 A KR800000885 A KR 800000885A KR 850001339 B1 KR850001339 B1 KR 850001339B1
Authority
KR
South Korea
Prior art keywords
acid
dioxide
solution
added
ethyl acetate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
KR1019800000885A
Other languages
English (en)
Korean (ko)
Inventor
쉴즈 무어 버나드
디이 캐롤 로니
알프레드 폴크만 로버트
Original Assignee
화이자 인코포레이티드
테렌스 제이. 겔라거
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 화이자 인코포레이티드, 테렌스 제이. 겔라거 filed Critical 화이자 인코포레이티드
Application granted granted Critical
Publication of KR850001339B1 publication Critical patent/KR850001339B1/ko
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Cosmetics (AREA)
KR1019800000885A 1979-03-05 1980-03-04 페니실란산 1,1-디옥사이드 및 그의 에스테르의 제조방법 Expired KR850001339B1 (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US1781079A 1979-03-05 1979-03-05
US1780879A 1979-03-05 1979-03-05
US17810 1979-03-05
US17808 1979-03-05

Publications (1)

Publication Number Publication Date
KR850001339B1 true KR850001339B1 (ko) 1985-09-19

Family

ID=26690337

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019800000885A Expired KR850001339B1 (ko) 1979-03-05 1980-03-04 페니실란산 1,1-디옥사이드 및 그의 에스테르의 제조방법

Country Status (36)

Country Link
KR (1) KR850001339B1 (enExample)
AR (1) AR225031A1 (enExample)
AT (1) AT366693B (enExample)
AU (1) AU522572B2 (enExample)
BG (1) BG33292A3 (enExample)
CH (1) CH644608A5 (enExample)
CS (1) CS215130B2 (enExample)
DD (1) DD149367A5 (enExample)
DE (1) DE3008257C2 (enExample)
DK (2) DK159852C (enExample)
EG (1) EG14437A (enExample)
ES (1) ES489185A0 (enExample)
FI (1) FI70024C (enExample)
FR (1) FR2450836B1 (enExample)
GB (1) GB2045755B (enExample)
GR (1) GR67234B (enExample)
HK (1) HK66587A (enExample)
HU (1) HU186304B (enExample)
IE (1) IE49535B1 (enExample)
IL (1) IL59515A (enExample)
IN (1) IN153685B (enExample)
IT (1) IT1130300B (enExample)
KE (1) KE3464A (enExample)
LU (1) LU82215A1 (enExample)
MX (1) MX6032E (enExample)
MY (1) MY8500319A (enExample)
NL (1) NL180317C (enExample)
NO (2) NO800618L (enExample)
PL (1) PL125197B1 (enExample)
PT (1) PT70897A (enExample)
RO (1) RO80112A (enExample)
SE (2) SE449103B (enExample)
SG (1) SG55884G (enExample)
SU (1) SU1192626A3 (enExample)
UA (1) UA6342A1 (enExample)
YU (1) YU42328B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4419284A (en) * 1981-03-23 1983-12-06 Pfizer Inc. Preparation of halomethyl esters (and related esters) of penicillanic acid 1,1-dioxide
IN159362B (enExample) * 1981-03-23 1987-05-09 Pfizer
US4360463A (en) 1981-09-02 1982-11-23 Pfizer Inc. Pure 6,6-diiodopenicillanic acid and process for its preparation
PT76526B (en) * 1982-04-19 1986-01-21 Gist Brocades Nv Preparation of 6-alpha-bromo- and/or 6,6-dibromopenicillanic acid 1,1-dioxides
IT1190897B (it) * 1982-06-29 1988-02-24 Opos Biochimica Srl Procedimento per la preparazione dell'estere 1-etossicarbonilossietilico dell'acido 6-(d(-)-alfa aminoalfa fenilacetamido)-penicillanico
US4606865A (en) * 1982-09-20 1986-08-19 Astra Lakemedel Aktiebolag Methods for the preparation of α-bromodiethylcarbonate
EP0139047A1 (en) * 1983-10-18 1985-05-02 Gist-Brocades N.V. Process for the preparation of 6,6-dibromopenicillanic acid 1,1-dioxide
EP0139048A1 (en) * 1983-10-18 1985-05-02 Gist-Brocades N.V. Process for the dehalogenation of 6,6-dibromopenicillanic acid 1,1-dioxide
US4596677A (en) * 1984-04-06 1986-06-24 Bristol-Myers Company Anhydropenicillin intermediates

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN149747B (enExample) * 1977-06-07 1982-04-03 Pfizer
CA1158639A (en) * 1978-12-11 1983-12-13 Eric M. Gordon 6-bromopenicillanic acid sulfone
DE3068390D1 (en) * 1979-01-10 1984-08-09 Beecham Group Plc Penicillin derivatives, process for their preparation and pharmaceutical compositions containing certain of these compounds
IE49881B1 (en) * 1979-02-13 1986-01-08 Leo Pharm Prod Ltd B-lactam intermediates

Also Published As

Publication number Publication date
DK145690D0 (da) 1990-06-14
SE8603309L (sv) 1986-08-04
MY8500319A (en) 1985-12-31
ES8103094A1 (es) 1981-02-16
YU42328B (en) 1988-08-31
HU186304B (en) 1985-07-29
GB2045755A (en) 1980-11-05
FI800661A7 (fi) 1980-09-06
IT1130300B (it) 1986-06-11
IL59515A0 (en) 1980-06-30
PL222448A1 (enExample) 1981-01-02
DE3008257C2 (de) 1984-03-01
SE8603309D0 (sv) 1986-08-04
FR2450836A1 (fr) 1980-10-03
PL125197B1 (en) 1983-04-30
UA6342A1 (uk) 1994-12-29
IE49535B1 (en) 1985-10-16
CS215130B2 (en) 1982-07-30
DK92680A (da) 1980-09-06
DK159852C (da) 1991-05-06
HK66587A (en) 1987-09-25
DK166353B (da) 1993-04-13
FR2450836B1 (fr) 1986-03-21
AT366693B (de) 1982-04-26
ATA119080A (de) 1981-09-15
EG14437A (en) 1984-09-30
DK159852B (da) 1990-12-17
YU58580A (en) 1983-02-28
NL180317B (nl) 1986-09-01
FI70024B (fi) 1986-01-31
IE800429L (en) 1980-09-05
KE3464A (en) 1984-10-12
IL59515A (en) 1983-02-23
IT8020367A0 (it) 1980-03-05
BG33292A3 (bg) 1983-01-14
SG55884G (en) 1985-03-08
NL180317C (nl) 1987-02-02
NO823127L (no) 1980-09-08
MX6032E (es) 1984-10-04
GR67234B (enExample) 1981-06-25
AU522572B2 (en) 1982-06-17
ES489185A0 (es) 1981-02-16
IN153685B (enExample) 1984-08-04
SE449103B (sv) 1987-04-06
DE3008257A1 (de) 1980-09-11
AR225031A1 (es) 1982-02-15
GB2045755B (en) 1983-01-26
DD149367A5 (de) 1981-07-08
DK145690A (da) 1990-06-14
NL8001285A (nl) 1980-09-09
CH644608A5 (de) 1984-08-15
FI70024C (fi) 1986-09-12
PT70897A (en) 1980-04-01
LU82215A1 (fr) 1980-09-24
RO80112A (ro) 1982-10-26
SU1192626A3 (ru) 1985-11-15
NO800618L (no) 1980-09-08
AU5610480A (en) 1980-09-11
DK166353C (da) 1993-09-06
SE8000512L (sv) 1980-09-06

Similar Documents

Publication Publication Date Title
KR840000797B1 (ko) 6β-하이드록시알킬페니실란산 유도체의 제조방법
US4234579A (en) Penicillanic acid 1,1-dioxides as β-lactamase inhibitors
US4276285A (en) Combinations of penicillanic acid 1,1-dioxide with 7-(D-2-[4-ethylpiperazin-2,3-dione-1-carboxamido]-2-[4-hydroxyphenyl]acetamido)-3-([1-methyl-5-tetrazolyl]thiomethyl)-3-desacetoxymethylcephalosporanic acid
KR850001339B1 (ko) 페니실란산 1,1-디옥사이드 및 그의 에스테르의 제조방법
US4256733A (en) Acetoxymethyl penam compounds as β-lactamase inhibitors
US4420426A (en) 6-Alpha-halopenicillanic acid 1,1-dioxides
CA1109859A (en) Thiooxime cephalosporin and penicillin derivatives
KR840000589B1 (ko) 6-β-치환된 페니실란산의 제조방법
US4260598A (en) Method for increasing antibacterial effectiveness of a β-lactam antibiotic
EP0181702B1 (en) 6-substituted penicillanic acid 1,1-dioxide compounds
JPS6033397B2 (ja) ペナム−1,1−ジオキシド
US4452796A (en) 6-Aminoalkylpenicillanic acid 1,1-dioxides as beta-lactamase inhibitors
EP0287734A1 (en) 2-Beta-substituted methyl-penam derivatives
US4714761A (en) 6,6-dihalopenicillanic acid 1,1-dioxides and process
US4762920A (en) 6,6-Dihalopenicillanic acid 1,1-dioxides
US4656263A (en) 6-β-substituted penicillanic acid compound free of the 6-α-epimer
JPS6145993B2 (enExample)
EP0002927B1 (en) Penicillanic acid derivatives, processes for their preparation and pharmaceutical compositions containing them
US4613462A (en) 6-substituted penicillanic acid 1,1-dioxide compounds
US4518530A (en) 6-β-Substituted penicillanic acids as β-lactamase inhibitors
US4517126A (en) Penicillanic acid derivative
KR810002025B1 (ko) 페니실란산 1, 1-디옥사이드의 제조방법
KR820000740B1 (ko) 페니실란산 1, 1-디옥사이드의 제조방법
CA1152982A (en) Process and intermediates for penicillanic acid, 1,1-dioxide and esters thereof
KR830001902B1 (ko) 폐니실란산유도체의 제조방법

Legal Events

Date Code Title Description
PA0109 Patent application

St.27 status event code: A-0-1-A10-A12-nap-PA0109

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PE0601 Decision on rejection of patent

St.27 status event code: N-2-6-B10-B15-exm-PE0601

PG1605 Publication of application before grant of patent

St.27 status event code: A-2-2-Q10-Q13-nap-PG1605

PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U11-oth-PR1002

Fee payment year number: 1

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 7

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 8

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 9

PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 19940920

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 19940920

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R13-asn-PN2301

St.27 status event code: A-5-5-R10-R11-asn-PN2301

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000